{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T22:03:02Z","timestamp":1780005782854,"version":"3.53.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.talanta.2026.129885","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:28:50Z","timestamp":1776814130000},"page":"129885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The multidimensional signature of oxysterols: Comparative RPLC-HRMS-based profiling of healthy and pancreatic tumour cell lines"],"prefix":"10.1016","volume":"308","author":[{"given":"Vito","family":"Nettis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5249-7168","authenticated-orcid":false,"given":"Andrea","family":"Castellaneta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3470-7045","authenticated-orcid":false,"given":"Noa","family":"Ndimurwanko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7059-528X","authenticated-orcid":false,"given":"Francesco","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Casieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Lionetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Giovannetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0595-9491","authenticated-orcid":false,"given":"Liam A.","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4811-8959","authenticated-orcid":false,"given":"Tommaso R.I.","family":"Cataldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8832-7072","authenticated-orcid":false,"given":"Cosima D.","family":"Calvano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.talanta.2026.129885_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.talanta.2026.129885_bib2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019 A systematic analysis for the global burden of disease study 2019","volume":"8","author":"Kocarnik","year":"2022","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.talanta.2026.129885_bib3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12029-015-9724-1","article-title":"A systematic review of the burden of pancreatic cancer in Europe: real-world impact on survival, quality of life and costs","volume":"46","author":"Carrato","year":"2015","journal-title":"J. Gastrointest. Cancer"},{"key":"10.1016\/j.talanta.2026.129885_bib4","first-page":"7","article-title":"Cancer statistics","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.talanta.2026.129885_bib5","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.dld.2018.08.008","article-title":"Pancreatic cancer: french clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC)","volume":"50","author":"Neuzillet","year":"2018","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.talanta.2026.129885_bib6","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s00595-019-01804-x","article-title":"Conversion surgery for initially unresectable pancreatic cancer: current status and unresolved issues","volume":"49","author":"Yoshitomi","year":"2019","journal-title":"Surg. Today"},{"key":"10.1016\/j.talanta.2026.129885_bib7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/annonc\/mdp332","article-title":"Tumor markers in pancreatic cancer: a european group on tumor markers (EGTM) status report","volume":"21","author":"Duffy","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.talanta.2026.129885_bib8","first-page":"105","article-title":"The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: an evidence based appraisal","volume":"3","author":"Ballehaninna","year":"2012","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.talanta.2026.129885_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10689-024-00394-z","article-title":"Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small lesions","volume":"23","author":"Boekestijn","year":"2024","journal-title":"Fam. Cancer."},{"key":"10.1016\/j.talanta.2026.129885_bib10","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.3748\/wjg.v27.i26.4045","article-title":"Biomarkers in the diagnosis of pancreatic cancer: are we closer to finding the golden ticket?","volume":"27","author":"O'Neill","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.talanta.2026.129885_bib11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.15698\/cst2019.12.205","article-title":"Metabolism remodeling in pancreatic ductal adenocarcinoma","volume":"3","author":"Li","year":"2019","journal-title":"Cell Stress"},{"key":"10.1016\/j.talanta.2026.129885_bib12","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.mehy.2013.08.024","article-title":"Warburg effect increases steady-state ROS condition in cancer cells through decreasing their antioxidant capacities (anticancer effects of 3-bromopyruvate through antagonizing Warburg effect)","volume":"81","author":"El Sayed","year":"2013","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.talanta.2026.129885_bib13","first-page":"1","article-title":"Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis","volume":"2019","author":"Su","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.talanta.2026.129885_bib14","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41589-020-0529-6","article-title":"Plasma membranes are asymmetric in lipid unsaturation, packing and protein shape","volume":"16","author":"Lorent","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.talanta.2026.129885_bib15","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/chemistry2020025","article-title":"Reactive sterol electrophiles: mechanisms of formation and reactions with proteins and amino acid nucleophiles","volume":"2","author":"Porter","year":"2020","journal-title":"Chemistry"},{"key":"10.1016\/j.talanta.2026.129885_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101380","article-title":"7-Ketocholesterol in disease and aging","volume":"29","author":"Anderson","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.talanta.2026.129885_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2026.466735","article-title":"Overcoming challenges in LC separation of oxysterols through guided design space modelling: a comparison of three stationary phases","volume":"1770","author":"Castellaneta","year":"2026","journal-title":"J. Chromatogr., A"},{"key":"10.1016\/j.talanta.2026.129885_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.chemphyslip.2011.06.006","article-title":"Pathways of cholesterol oxidation via non-enzymatic mechanisms","volume":"164","author":"Iuliano","year":"2011","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.talanta.2026.129885_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2019.106381","article-title":"Oxysterols as lipid mediators: their biosynthetic genes, enzymes and metabolites","volume":"147","author":"Griffiths","year":"2020","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.talanta.2026.129885_bib20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1146\/annurev-pharmtox-010715-103233","article-title":"Oxysterols: old tale, new twists","volume":"56","author":"Luu","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.talanta.2026.129885_bib21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bcp.2013.02.029","article-title":"Oxysterols in cancer cell proliferation and death","volume":"86","author":"De Weille","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.talanta.2026.129885_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2023.106354","article-title":"Effects of 7-ketocholesterol on tamoxifen efficacy in breast carcinoma cell line models in vitro","volume":"232","author":"Spalenkova","year":"2023","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.talanta.2026.129885_bib23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/sj.cdd.4401530","article-title":"Different apoptotic mechanisms are involved in the antiproliferative effects of 7\u03b2-hydroxysitosterol and 7\u03b2-hydroxycholesterol in human colon cancer cells","volume":"12","author":"Roussi","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.talanta.2026.129885_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2019.105566","article-title":"Plasma oxysterol levels in luminal subtype breast cancer patients are associated with clinical data","volume":"197","author":"Kloudova-Spalenkova","year":"2020","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.talanta.2026.129885_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016631","article-title":"The cholesterol metabolite 25-Hydroxycholesterol activates estrogen receptor \u03b1-Mediated signaling in cancer cells and in cardiomyocytes","volume":"6","author":"Lappano","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.talanta.2026.129885_bib26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jsbmb.2016.06.010","article-title":"Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: results of the OXYTAM study","volume":"169","author":"Dalenc","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.talanta.2026.129885_bib27","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.1241908","article-title":"27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology","volume":"342","author":"Nelson","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.talanta.2026.129885_bib28","article-title":"Pathophysiological role of 27-hydroxycholesterol in human diseases","volume":"83","author":"Kim","year":"2022","journal-title":"Adv. Bio. Regul."},{"key":"10.1016\/j.talanta.2026.129885_bib29","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.18632\/oncotarget.6808","article-title":"Metabolomic profile in pancreatic cancer patients: a consensusbased approach to identify highly discriminating metabolites","volume":"7","author":"Di Gangi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.talanta.2026.129885_bib30","doi-asserted-by":"crossref","first-page":"E6219","DOI":"10.1073\/pnas.1613332113","article-title":"24-Hydroxycholesterol participates in pancreatic neuroendocrine tumor development","volume":"113","author":"Soncini","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.talanta.2026.129885_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1360629","article-title":"High hypoxia status in pancreatic cancer is associated with multiple hallmarks of an immunosuppressive tumor microenvironment","volume":"15","author":"Sadozai","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.talanta.2026.129885_bib32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jsbmb.2015.11.017","article-title":"New methods for analysis of oxysterols and related compounds by LC\u2013MS","volume":"162","author":"Griffiths","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.talanta.2026.129885_bib33","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/CCM.0000000000002328","article-title":"Exosomes in critical illness","volume":"45","author":"Terrasini","year":"2017","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.talanta.2026.129885_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1537313","article-title":"Exosomes in hypoxia: generation, secretion, and physiological roles in cancer progression","volume":"16","author":"Mu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.talanta.2026.129885_bib35","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1021\/acs.jproteome.5c00082","article-title":"Novel PPT+SEC workflow for high-sensitivity extracellular vesicle proteomics from cell media","volume":"24","author":"Botto","year":"2025","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.talanta.2026.129885_bib36","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1038\/s41598-020-59225-7","article-title":"Ticagrelor enhances release of anti-hypoxic cardiac progenitor cell-derived exosomes through increasing cell proliferation in vitro","volume":"10","author":"Casieri","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.talanta.2026.129885_bib37","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1194\/jlr.D022285","article-title":"A comprehensive method for extraction and quantitative analysis of sterols and secosteroids from human plasma","volume":"53","author":"McDonald","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.talanta.2026.129885_bib38","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3390\/ijms24010885","article-title":"Diagnostic and prognostic role of extracellular vesicles in pancreatic cancer: current evidence and future perspectives","volume":"24","author":"Nicoletti","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.talanta.2026.129885_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914026005412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914026005412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T21:24:38Z","timestamp":1780003478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914026005412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":39,"alternative-id":["S0039914026005412"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2026.129885","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The multidimensional signature of oxysterols: Comparative RPLC-HRMS-based profiling of healthy and pancreatic tumour cell lines","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2026.129885","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"129885"}}